Facebook Pixel Code
Arthur & Sonia Labatt Brain Tumour Research Centre

BTRC News 2012-13

December 2013

Canadian researchers lead groundbreaking discovery in deadly childhood cancer
A new study by Canadian researchers may pave the way for more effective treatment of an aggressive and deadly type of brain tumour, known as ETMR/ETANTR. The tumour, which is seen only in children under four, is almost always fatal, despite aggressive treatment. learn more

Photo of participants
Photo: S. Waldbillig, Courtesy: Luxemburger Wort

April 2013

Dr. Michael Taylor joins ‘Dream Team’ of childhood cancer researchers details 

March 2013

Labatt BTRC signs historic collaborative research document with CRP-Santé Luxembourg:

Dr. James Rutka travelled to Luxembourg on March 7, 2013, to visit the Norlux Neuro-Oncology Research Laboratory in Luxembourg City. There, he signed a collaborative document celebrating the research collaboration agreement between the Labatt BTRC and CRP-Santé.  Dr. Rutka gave an overview of the BTRC to those in Luxembourg, and was asked to speak before the Minister of the Economy and Foreign Trade, The Honourable Etienne Schneider. Shown in the photograph following the signing of the document are:  Dr. Rolf Bjerkvig, Research Scientist, Norlux Laboratory; Dr. Jean-Claude Schmit, CEO, CRP-Santé;  Mr. Frank Gansen, President CRP-Santé; the Hon. Etienne Schneider; and Dr. James Rutka.

January 2013

Dr. Paul Kongkham graduate of the University of Toronto joined this centre as an Adjunct Scientist. He did his postdoctoral work at Baylor. He is a Neurosurgeon at the Western Hospital and will be doing his research at the Centre's facilities at Sick Kids.

August 2012

SickKids researchers uncover molecular markers for rare form of brain tumour
“CNS PNETs may appear very similar to many other tumours but don’t behave the same, so this group can be very difficult to diagnose and design specific treatment for,” says Dr. Annie Huang, Principal Investigator of the study. learn more

July 2012

International collaboration may spark major shift in treatment of some kids with brain cancer
“By studying over 1,000 samples we now better understand the four groups and can therefore identify them faster and treat them more specifically,” says Dr. Michael D. Taylor, Principal Investigator of the study. learn more

April 2012

Xiaochong Wu from the Taylor lab is the winner of the 2012 Peter Steck Young Investigator’s Award,  funded by the Pediatric Brain Tumor Foundation.

This is prestigious award helps illuminate our research successes on both sides of the border.  Xiaochong will be presenting her research at the M.D. Anderson Cancer Center in conjunction with the Steck Lectureship on April 29, 2012.